Grünenthal Gmbh
Clinical trials sponsored by Grünenthal Gmbh, explained in plain language.
-
New painkiller GRT7041 tested in humans for first time
Symptom relief Recruiting nowThis early-stage trial tests a new drug called GRT7041 in 70 healthy volunteers to see if it is safe and how the body processes it. The study involves giving single or multiple doses and monitoring for side effects. It is a first step in developing a potential new treatment for p…
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Scientists track experimental Drug's journey in healthy men
Knowledge-focused Recruiting nowThis early-stage study gives 10 healthy men a single dose of GRT6019 with a radioactive tracer to see how the drug is broken down and eliminated. Researchers will measure radioactivity in urine and stool to understand the drug's metabolism. The study does not aim to treat any con…
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC